{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Vorobjeva NV"],"journal":["Frontiers in pharmacology"],"pagination":["609508"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7878366"],"repository":["biostudies-literature"],"pubmed_title":["Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19."],"pmcid":["PMC7878366"],"pubmed_authors":["Vorobjeva NV","Chernyak BV","Sud'ina GF"],"additional_accession":[]},"is_claimable":false,"name":"Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-04-22T16:14:13.937Z","creation":"2025-02-19T04:53:15.442Z"},"accession":"S-EPMC7878366","cross_references":{"pubmed":["33584318"],"doi":["10.3389/fphar.2021.609508"]}}